Evidence map›Paper›PMID 34487636›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

Life expectancy without a transplant for status 1A liver transplant candidates.

Nicholas L Wood, Douglas N VanDerwerken, Elizabeth A King, Dorry L Segev, Sommer E Gentry

Abstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicholas L WoodDepartment of Mathematics, United States Naval Academy, Annapolis, Maryland, USA.ORCID 0000-0003-0768-3759
Douglas N VanDerwerkenDepartment of Mathematics, United States Naval Academy, Annapolis, Maryland, USA.ORCID 0000-0002-1761-4960
Elizabeth A KingDepartment of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Dorry L SegevDepartment of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA.ORCID 0000-0002-1924-4801
Sommer E GentryDepartment of Mathematics, United States Naval Academy, Annapolis, Maryland, USA.ORCID 0000-0003-4530-8917

Funding

Reducing geographic disparities in kidney and liver allocationR01DK111233 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WARREN, DANIEL S · 2016 to 2019
$2.5M
Patient Oriented Research in Solid Organ TransplantationK24AI144954 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SEGEV, DORRY L. · 2020 to 2024
$956k
Patient Oriented Research in Kidney Disease and Transplant SurgeryK24DK101828 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SEGEV, DORRY L. · 2014 to 2018
$922k
NIAID NIH HHS K24 AI144954NIDDK NIH HHS K24 DK101828NIDDK NIH HHS R01 DK111233
6 · The paper itself

Abstract

Status 1A liver transplant candidates are given the highest medical priority for the allocation of deceased donor livers. Organ Procurement and Transplantation Network (OPTN) policy requires physicians to certify that a candidate has a life expectancy without a transplant of less than 7 days for that candidate to be given status 1A. Additionally, candidates receiving status 1A must have one of six medical conditions listed in policy. Using Scientific Registry of Transplant Recipients data from all prevalent liver transplant candidates from 2010 to 2020, we used a bias-corrected Kaplan-Meier model to calculate the survival of status 1A candidates and to determine their life expectancy without a transplant. We found that status 1A candidates have a life expectancy without a transplant of 24 (95% CI 20-46) days-over three times longer than what policy requires for status 1A designation. We repeated the analysis for subgroups of status 1A candidates based on the medical conditions that grant status 1A. We found that none of these subgroups met the life expectancy requirement. Harmonizing OPTN policy with observed data would sustain the integrity of the allocation process.

Indexed as

Heart TransplantationLiver TransplantationTissue and Organ ProcurementHumansLife ExpectancyWaiting Listsethics and public policylaw/legislationliver transplantation/hepatologymathematical modelorgan allocationorgan procurement and allocationOrgan Procurement and Transplantation Network (OPTN)patient survivalstatisticstranslational research/science

Identifiers

PMID34487636
PMCPMC8720063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.